Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-25

Clinical Trial Update: Harmonized AS/MQ Efficacy Study - Thailand [Phase 4]

View source ↗

Summary

Phase 4 harmonized efficacy study of an artesunate-mefloquine combination for malaria conducted in Thailand has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artesunate (artesunate)
  • Mefloquine (Mefloquine)

Snippet

Sponsor: Armed Forces Research Institute of Medical Sciences, Thailand | Conditions: Malaria | Phase 4 | Status: COMPLETED